Testing for SARS-CoV-2: Can We Stop at 2?
-
Authors
-
-
Lee, Tau Hong1, 2, 3, 4
-
Junhao Lin, Ray1, 2
-
Lin, Raymond T P1
-
Barkham, Timothy2, 4
-
Rao, Pooja2, 3
-
Leo, Yee-Sin1, 2, 3, 4, 5
-
Chien Lye, David1, 2, 3, 4
-
Young, Barnaby1, 2, 3
-
1
National Centre for Infectious Diseases, Singapore.
,
(Singapore)
-
2
Tan Tock Seng Hospital, Singapore.
,
(Singapore)
-
3
Lee Kong Chian School of Medicine, Singapore.
,
(Singapore)
-
4
Yong Loo Lin School of Medicine, Singapore.
,
(Singapore)
-
5
Saw Swee Hock School of Public Health, Singapore.
,
(Singapore)
- Type
- Published Article
- Journal
-
Clinical Infectious Diseases
- Publisher
-
Oxford University Press
- Publication Date
-
Nov 19, 2020
- Volume
-
71
- Issue
-
16
- Pages
-
2246–2248
- Identifiers
-
DOI: 10.1093/cid/ciaa459
-
PMID: 32306042
- Source
-
Medline
- Keywords
-
- Language
-
English
- License
-
Unknown
Abstract
The COVID-19 epidemic requires accurate identification and isolation of confirmed cases for effective control. This report describes the effectiveness of our testing strategy and highlights the importance of repeat testing in suspected cases in our cohort. © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 12/04/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32306042
Report this publication